학술논문

Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease
Document Type
article
Source
Hypertension. 73(4)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Cardiovascular
Clinical Research
Kidney Disease
Hypertension
Detection
screening and diagnosis
4.1 Discovery and preclinical testing of markers and technologies
2.1 Biological and endogenous factors
Aetiology
Inflammatory and immune system
Renal and urogenital
Good Health and Well Being
Adult
Aged
Antihypertensive Agents
Biomarkers
Blood Pressure
Comorbidity
Cross-Sectional Studies
Cytokines
Drug Resistance
Female
Glomerular Filtration Rate
Humans
Inflammation
Male
Middle Aged
Renal Insufficiency
Chronic
Risk Factors
United States
Young Adult
cardiovascular diseases
hypertension
inflammation
patients
renal insufficiency
chronic
renal insufficiency
chronic
Cardiorespiratory Medicine and Haematology
Public Health and Health Services
Cardiovascular System & Hematology
Cardiovascular medicine and haematology
Clinical sciences
Language
Abstract
Apparent treatment-resistant hypertension (ATRH) is highly prevalent and associated with cardiovascular disease risk in patients with chronic kidney disease. We analyzed the association of inflammatory biomarkers with ATRH and its complications in patients with chronic kidney disease. ATRH was defined as blood pressure ≥140/90 mm Hg while taking ≥3 antihypertensive medications or blood pressure